NasdaqCM - Delayed Quote • USD
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 6:34 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| COHEN YUVAL Chief Executive Officer | Stock Award(Grant) | Feb 12, 2024 | 84,400 |
| CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | Purchase | Mar 8, 2024 | -- |
| DISCORDIA ROBERT PAUL Chief Operating Officer | Purchase | Mar 17, 2020 | 35,490 |
| HOCHMAN DAVID P Director | Purchase | Mar 15, 2019 | -- |
| HOLMER ALAN F Director | Conversion of Exercise of derivative security | Jan 26, 2024 | 1,379 |
| JENKINS JOHN KENNETH M.D. Director | Purchase | Mar 15, 2019 | 1,000 |
| MILLIAN CRAIG STUART Chief Operating Officer | Purchase | Aug 10, 2022 | 27,000 |
| MORAN SEAN F Chief Financial Officer | Conversion of Exercise of derivative security | Apr 10, 2024 | 48,605 |
| SMETHURST DOMINIC Officer | Stock Award(Grant) | Feb 27, 2024 | 50,000 |
| WHITE BARBARA Officer | Purchase | Mar 17, 2020 | 206,217 |
Related Tickers
JANX Janux Therapeutics, Inc.
47.39
+0.62%
VINC Vincerx Pharma, Inc.
0.7300
-18.59%
ELEV Elevation Oncology, Inc.
3.6200
-0.69%
CADL Candel Therapeutics, Inc.
6.39
-0.62%
APM Aptorum Group Limited
5.28
-3.65%
KURA Kura Oncology, Inc.
19.65
+3.42%
CGEM Cullinan Therapeutics, Inc.
25.30
+31.43%
DAWN Day One Biopharmaceuticals, Inc.
14.92
+12.94%
MRUS Merus N.V.
45.04
+0.24%
SLNO Soleno Therapeutics, Inc.
37.89
+1.47%